In vitro study of low molecular weight heparin effect on cell growth and cell invasion in primary cell cultures of high-grade gliomas

Oncology Research

Volumn 16, Issue 5, 2006, Pages 245-250

  Balzarotti, Marco ^a   Fontana, Federica ^a   Marras, Carlo ^a   Boiardi, Amerigo ^a   Croci, Danilo ^a   Ciusani, Emilio ^a   Salmaggi, Andrea ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Glioma; Invasion; Low molecular weight heparin (LMWH); Primary cell cultures

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROTEINASE ACTIVATED RECEPTOR 1;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT CANCER;

EID: 33846847643     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783981053     Document Type: Article

References (17)

1. Lee, A. Y.; Rickles, F. R.; Julian, J. A.; Gent, M.; Baker, R. I.; Bowden, C.; Kakkar, A. K.; Prins, M.; Levine, M. N. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J. Clin. Oncol. 23:2123-2129; 2005.
2. Klerk, C. P.; Smorenburg, S. M.; Otten, H. M.; Lensing, A. W.; Prins, M. H.; Piovella, F.; Prandoni, P.; Bos, M. M.; Richel, D. J.; van Tienhoven, G.; Buller, H. R. The effect of low molecular weight heparin on survival in patients with advanced malignancy. J. Clin. Oncol. 23:2130-2135; 2005.
3. Kakkar, A. K.; Levine, M. N.; Kadziola, Z.; Lemoine, N. R.; Low, V.; Patel, H. K.; Rustin, G.; Thomas, M.; Quigley, M.; Williamson, R. C. Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS). J. Clin. Oncol. 22:1944-1948; 2004.
4. Altinbas, M.; Coskun, H. S.; Er, O.; Ozkan, M.; Eser, B.; Unal, A.; Cetin, M.; Soyuer, S. A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. J. Thromb. Haemost. 2:1266-1271; 2004.
5. Falanga, A.; Piccioli, A. Effect of anticoagulant drugs in cancer. Curr. Opin. Pulm. Med. 11:403-407; 2005.
6. Abildgaard, U. Heparin/low molecular weight heparin and tissue factor pathway inhibitor. Haemostasis 23(Suppl. 1):103-106; 1993.
7. Ornstein, D. L.; Zacharski, L. R. Activity of heparins in experimental models of malignancy: Possible explanations for anticancer effects in humans. Clin. Hemorheol. Microcirc. 26:33-40; 2002.
8. Levin, V. A.; Leibel, S. A.; Gutin, P. H. Neoplasms of the central nervous system. In: De Vita, V. T.; Hellman, S.; Rosenberg, S. A., eds. Cancer: Principles and practice of oncology, 5th ed. Philadelphia: Lippincott-Raven Publishers; 1997:2022-2082.
9. Schweitzer, T.; Vince, G. H.; Herbold, C.; Roosen, K.; Tonn, J. C. Extraneural metastases of primary brain tumors. J. Neurooncol. 53:107-114; 2001.
10. Ornstein, D. L.; Meehan, K. R.; Zacharski, L. R. The coagulation system as a target for the treatment of human gliomas. Semin. Thromb. Hemost. 28:19-28; 2002.
11. Hua, Y.; Tang, L.; Keep, R. F.; Schallert, T.; Fewel, M. E.; Muraszko, K. M.; Hoff, J. T.; Xi, G. The role of thrombin in gliomas. J. Thromb. Haemost. 3:1917-1923; 2005.
12. Kaufmann, R.; Patt, S.; Schaffberg, H.; Halff, R.; Neupert, G.; Nowak, G. Functional thrombin receptor PAR1 in primary cultures of human glioblastoma cells. Neuroreport 9:709-712; 1998.
13. Junge, C. E.; Lee, C. J.; Hubbard, K. B.; Zhang, Z.; Olson, J. J.; Hepler, J. R.; Brat, D. J.; Traynelis, S. F. Protease-activated receptor-1 in human brain: Localization and functional expression in astrocytes. Exp. Neurol. 188:94-103; 2004.
14. Martin, C. B.; Mahon, G. M.; Klinger, M. B.; Kay, R. J.; Symons, M.; Der, C. J.; Whitahead, I. P. The thrombin receptor, PAR1, causes transformation by activation of Rho-mediated signalling pathways. Oncogene 20:1953-1963; 2001.
15. Karti, S. S.; Ovali, E.; Ozgur, O.; Yilmaz, M.; Sonmez, M.; Ratip, S.; Ozdemir, F. Induction of apoptosis and inhibition of growth of human hepatoma HepG2 cells by heparin. Hepatogastroenterology 50:1864-1866; 2003.
16. Bereczky, B.; Gilly, R.; Raso, E.; Vago, A.; Timar, J.; Tovari, J. Selective antimetastatic effect of heparins in preclinical human melanoma models is based on inhibition of migration and microvascular arrest. Clin. Exp. Metastasis 22:69-76; 2005.
17. Aguiar, C. B.; Lobao-Soares, B.; Alvarez-Silva, M.; Trentin, A. G. Glycosaminoglycans modulate C6 glioma cell adhesion to extracellular matrix components and alter cell proliferation and cell migration. BMC Cell Biol. 6:31; 2005.